[pending] Macy's Recalls Arch Studio Tea Kettles Due to Risk of Serious Injury from Burn Hazard
Pending LLM rewrite. Source: CPSC 26412.
- Product
- Arch Studio Tea Kettle
- Category
- Consumer Product
- Distribution
- Distributed nationwide
State
19,713 recalls have nationwide distribution and so reach Oklahoma. 0 additional recalls listed Oklahoma specifically in their distribution scope.
Most US product recalls have nationwide distribution — the manufacturer ships into every state and the recall sweeps the same way. We include those in this listing because they affect Oklahoma consumers even though the source notice doesn’t name the state. State-specific recalls are usually for products with regional distribution (a regional dairy, a local store brand) or where the agency was able to narrow the affected shipments to specific destinations.
If you’re checking whether a recall affects your purchase, the recall detail page lists the exact production lot codes, UPCs, and best-by dates. Match those against your package — distribution scope is a starting filter, not the final answer.
Pending LLM rewrite. Source: CPSC 26412.
Pending LLM rewrite. Source: CPSC 26414.
Pending LLM rewrite. Source: CPSC 26411.
Pending LLM rewrite. Source: FDA_DEVICE Z-1716-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0440-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0427-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0436-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1723-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0444-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0426-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0443-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0442-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0439-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0424-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0435-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0432-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0433-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1721-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1715-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1720-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1653-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1713-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0448-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0430-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1714-2026.